Orphagen Pharmaceuticals, Inc. - Product Pipeline Review - 2014 On 11thNovember 2014
Summary Orphagen Pharmaceuticals, Inc. - Product Pipeline Review - 2014, provides an overview of the Orphagen Pharmaceuticals, Inc.s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Orphagen Pharmaceuticals, Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-orphagen-pharmaceuticals-inc-product-pipeline-review-2014-126977 Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope - The report provides brief overview of Orphagen Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Orphagen Pharmaceuticals, Inc.s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Orphagen Pharmaceuticals, Inc.s pipeline products
Reasons to buy - Evaluate Orphagen Pharmaceuticals, Inc.s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Orphagen Pharmaceuticals, Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Orphagen Pharmaceuticals, Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Orphagen Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Orphagen Pharmaceuticals, Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Orphagen Pharmaceuticals, Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Table of Content List of Tables 3 List of Figures 3 Orphagen Pharmaceuticals, Inc. Snapshot 4 Orphagen Pharmaceuticals, Inc. Overview 4 Key Information 4 Key Facts 4 Orphagen Pharmaceuticals, Inc. - Research and Development Overview 5 Key Therapeutic Areas 5 Orphagen Pharmaceuticals, Inc. - Pipeline Review 7 Pipeline Products by Stage of Development 7 Pipeline Products - Monotherapy 8 Orphagen Pharmaceuticals, Inc. - Pipeline Products Glance 9 Orphagen Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 9 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Phase I Products/Combination Treatment Modalities 9 Orphagen Pharmaceuticals, Inc. - Early Stage Pipeline Products 10 Discovery Products/Combination Treatment Modalities 10 Orphagen Pharmaceuticals, Inc. - Drug Profiles 11 OR-1050 11 Product Description 11 Mechanism of Action 11 R&D Progress 11 Small Molecules to Antagonize Steroidogenic Factor-1 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 Small Molecules to Modulate Nuclear Receptor for Circadian Rhythm Sleep Disorders 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 Small Molecules to Modulate Nuclear Receptors for AMD 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 Small Molecules to Modulate Nuclear Receptors for GBM 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 Small Molecules to Modulate Nuclear Receptors for Retinitis Pigmentosa 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Orphagen Pharmaceuticals, Inc. - Pipeline Analysis 18 Orphagen Pharmaceuticals, Inc. - Pipeline Products by Target 18 Orphagen Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 19 Orphagen Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 20 Orphagen Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 21 Orphagen Pharmaceuticals, Inc. - Locations And Subsidiaries 22 Head Office 22 Appendix 23 Methodology 23 Coverage 23 Secondary Research 23 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Primary Research 23 Expert Panel Validation 23 Contact Us 24 Disclaimer 24 List Of Tables Orphagen Pharmaceuticals, Inc., Key Information 4 Orphagen Pharmaceuticals, Inc., Key Facts 4 Orphagen Pharmaceuticals, Inc. - Pipeline by Indication, 2014 6 Orphagen Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 7 Orphagen Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 8 Orphagen Pharmaceuticals, Inc. - Phase I, 2014 9 Orphagen Pharmaceuticals, Inc. - Discovery, 2014 10 Orphagen Pharmaceuticals, Inc. - Pipeline by Target, 2014 18 Orphagen Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2014 19 Orphagen Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2014 20 Orphagen Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2014 21 List Of Figures Orphagen Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2014 6 Orphagen Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2014 7 Orphagen Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2014 8 Orphagen Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2014 18 Orphagen Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2014 20 Orphagen Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2014 21
Report Price: Licence Type
Price
$ 1500
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Site Licence
$ 3000
Enterprise Wide Licence
$ 4500
Related Reports: Spain Wound Debridement Devices Market Outlook to 2020
Russia Wound Debridement Devices Market Outlook to 2020 South Korea Wound Debridement Devices Market Outlook to 2020 Germ Cell Tumors - Pipeline Review, H2 2014 Hormone-Sensitive Prostate Cancer - Pipeline Review, H2 2014 Retinoblastoma - Pipeline Review, H2 2014 Leiomyosarcoma - Pipeline Review, H2 2014 Metastatic Uveal Melanoma - Pipeline Review, H2 2014 Retinopathy Of Prematurity - Pipeline Review, H2 2014 Nerve Gas & Pestiside Poisioning - Pipeline Review, H2 2014
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Orphagen Pharmaceuticals, Inc. - Product Pipeline Review – 2014 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
http://www.jsbmarketresearch.com/healthcare-medical/r-orphagenpharmaceuticals-inc-product-pipeline-review-2014-126977
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/